Figure 6.
Evaluation of treatment responsiveness in the TCGA cohort. Responsiveness to the chemical drugs 5-fluorouracil (A), mitomycine C (B), and paclitaxel (C) in the TCGA cohort. Responsiveness to the targeted drugs lapatinib (D), FH535 (E), and sorafenib (F) in the TCGA cohort. (G) Tide scores of patients in the TCGA cohort. *** p < 0.001.